Remdesivir maintains antiviral potency against clinically relevant SARS-CoV-2 Nsp12 substitutions

Venice Du Pont, Dong Han, Jiani Li, Lauren Rodriguez, Arya Vijjapurapu, Bandita Parhy, Jasmine Moshiri, Kristen Andreatta, Danielle P. Porter, Charlotte Hedskog, John P. Bilello, Hongmei Mo, Caleb Marceau

doi:10.1016/j.antiviral.2026.106533

CrossrefInfo card

Remdesivir maintains antiviral potency against clinically relevant SARS-CoV-2 Nsp12 substitutions

Venice Du Pont, Dong Han, Jiani Li, Lauren Rodriguez, Arya Vijjapurapu, Bandita Parhy, Jasmine Moshiri, Kristen Andreatta, Danielle P. Porter, Charlotte Hedskog, John P. Bilello, Hongmei Mo, Caleb Marceau

Antiviral Research · 2026-11 · 255 · 106533

DOI: 10.1016/j.antiviral.2026.106533 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Venice Du Pont, Dong Han, Jiani Li, Lauren Rodriguez, Arya Vijjapurapu, Bandita Parhy, Jasmine Moshiri, Kristen Andreatta, Danielle P. Porter, Charlotte Hedskog, John P. Bilello, Hongmei Mo, Caleb Marceau
Journal: Antiviral Research
Year of publication: 2026
Volume / Issue: 255
Pages: 106533
Publisher: Elsevier BV
DOI: 10.1016/j.antiviral.2026.106533
ISSN: 0166-3542
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.